Research Article

MicroRNA Expression in Cutaneous Lupus: A New Window to Understand Its Pathogenesis

Figure 2

(a) Representative gating strategy of each cell population of CD4 effector T cells. (b) Representative gating strategy of each cell population of regulatory cells of a DLE patient. Percentages of circulating (c) CD4+/CD161-/IL-22+ cells, (d) CD4+/CD161+/IL-17A+ cells, (e) CD4+/CD25-/IL-4+ cells, (f) CD4+/CD25-/IFN-γ+ cells, (g) CD4+/CD25hi/Foxp3+ cells, (h) CD19+/CD38hi/IL-10+ cells, and (i) CD123+/CD196+/IDO+ cells. The results are expressed as the mean (horizontal yellow line), median (horizontal black line), and 5th/95th percentiles and . SCLE: subacute cutaneous lupus erythematosus; DLE: discoid lupus erythematosus; HD: healthy donors.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)